196 related articles for article (PubMed ID: 26633178)
1. Chemotherapy with Gemcitabine and Cisplatin for Advanced Ductal Adenocarcinoma of the Prostate: Clinical Courses of Two Patients.
Kamiyama Y; Mitsuzuka K; Watanabe M; Kawamorita N; Yamada S; Kaiho Y; Ito A; Nakagawa H; Arai Y
Tohoku J Exp Med; 2015 Dec; 237(4):317-21. PubMed ID: 26633178
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate antigen 19-9-positive prostatic ductal adenocarcinoma effectively treated with cisplatin and gemcitabine.
Kato T; Hashimoto Y; Okada S; Tozawa K; Takahashi S; Kohri K
Int J Urol; 2007 Dec; 14(12):1103-6. PubMed ID: 18036053
[TBL] [Abstract][Full Text] [Related]
3. [Short-term efficacy of combined chemotherapy of gemcitabine and cisplatin on advanced hormone refractory prostate cancer].
Qin ZK; Yang GW; Zhou FJ; Han H; Liu ZW; Zhou NN; Wu ZG
Ai Zheng; 2004 Dec; 23(12):1700-3. PubMed ID: 15601564
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer.
Jang J; Kim HK; Cho BC; Lee KH; Yun HJ; Woo IS; Song HS; Ryoo HM; Kim CH; Sun DS; Shin JW
Cancer Chemother Pharmacol; 2017 May; 79(5):873-880. PubMed ID: 28341958
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers.
Culine S; El Demery M; Lamy PJ; Iborra F; Avancès C; Pinguet F
J Urol; 2007 Sep; 178(3 Pt 1):844-8; discussion 848. PubMed ID: 17631339
[TBL] [Abstract][Full Text] [Related]
7. [Non-small cell lung cancer with liver metastasis responsive to gemcitabine--a case report].
Sakurai T; Oura S; Yoshimasu T; Tanino H; Kokawa Y; Nakamura T; Matsuyama K; Naito Y
Gan To Kagaku Ryoho; 2001 May; 28(5):707-10. PubMed ID: 11383223
[TBL] [Abstract][Full Text] [Related]
8. [Pathological complete response to gemcitabine and cisplatin chemotherapy for advanced upper tract urothelial carcinoma: a case report].
Matsuki M; Takahashi A; Katou S; Takayanagi A; Takagi Y; Kamata K
Nihon Hinyokika Gakkai Zasshi; 2013 Jan; 104(1):33-7. PubMed ID: 23457933
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with gemcitabine with isolated lung perfusion for the treatment of pulmonary metastases.
Van Putte BP; Hendriks JM; Romijn S; Pauwels B; Vermorken JB; Van Schil PE
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):125-30. PubMed ID: 15999051
[TBL] [Abstract][Full Text] [Related]
10. [Two cases of inoperable advanced bileduct cancer treated effectively with a gemcitabine/cisplatin combination].
Nakamura T; Kobayashi N; Saito J; Ikeda K; Okusawa S; Sagae S; Iwata K; Kurihara E
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1893-6. PubMed ID: 19920395
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas.
Ko AH; Dito E; Schillinger B; Venook AP; Bergsland EK; Tempero MA
J Clin Oncol; 2006 Jan; 24(3):379-85. PubMed ID: 16344320
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer.
Yang CH; Tsai CM; Wang LS; Lee YC; Chang CJ; Lui LT; Yen SH; Hsu C; Cheng AL; Liu MY; Chiang SC; Chen YM; Luh KT; Huang MH; Yang PC; Perng RP
Br J Cancer; 2002 Jan; 86(2):190-5. PubMed ID: 11870504
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder.
Malik IA; Aziz Z; Zaidi SH; Sethuraman G
Am J Clin Oncol; 2003 Apr; 26(2):174-7. PubMed ID: 12714891
[TBL] [Abstract][Full Text] [Related]
14. Phase I dose-escalation trial of gemcitabine and cisplatin for advanced non-small-cell lung cancer: usefulness of mathematic modeling to determine maximum-tolerable dose.
Shepherd FA; Burkes R; Cormier Y; Crump M; Feld R; Strack T; Schulz M
J Clin Oncol; 1996 May; 14(5):1656-62. PubMed ID: 8622085
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin plus gemcitabine as a salvage schedule for hormone-refractory prostate adenocarcinoma.
Santisteban M; Pérez-Gracia JL; Ceballos J; Vivas I; García-Foncillas J
Clin Transl Oncol; 2008 Jun; 10(6):372-4. PubMed ID: 18558585
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer.
Ueno H; Okusaka T; Ikeda M; Morizane C; Ogura T; Hagihara A; Tanaka T
Jpn J Clin Oncol; 2007 Jul; 37(7):515-20. PubMed ID: 17675286
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer.
Brodowicz T; Wolfram RM; Köstler WJ; Tomek S; Vaclavik I; Steger GG; Teleky B; Függer R; Jakesz R; Zielinski CC
Anticancer Drugs; 2000 Sep; 11(8):623-8. PubMed ID: 11081453
[TBL] [Abstract][Full Text] [Related]
18. [Refractory non-small-cell lung cancer responding to combination chemotherapy with gemcitabine and cisplatin].
Miyazawa M; Hyougotani A; Koyama H; Haba T; Katoh K; Muramatsu A; Ozawa K
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1227-30. PubMed ID: 12146004
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.
Gatzemeier U; Groth G; Butts C; Van Zandwijk N; Shepherd F; Ardizzoni A; Barton C; Ghahramani P; Hirsh V
Ann Oncol; 2004 Jan; 15(1):19-27. PubMed ID: 14679114
[TBL] [Abstract][Full Text] [Related]
20. CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin.
Heinemann V; Schermuly MM; Stieber P; Schulz L; Jüngst D; Wilkowski R; Schalhorn A
Anticancer Res; 1999; 19(4A):2433-5. PubMed ID: 10470171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
